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Abstract: Rhodothermus marinus is a halophilic extreme thermophile, with potential as a model
organism for studies of the structural basis of antibiotic resistance. In order to facilitate genetic studies
of this organism, we have surveyed the antibiotic sensitivity spectrum of R. marinus and identified
spontaneous antibiotic-resistant mutants. R. marinus is naturally insensitive to aminoglycosides,
aminocylitols and tuberactinomycins that target the 30S ribosomal subunit, but is sensitive to all 50S
ribosomal subunit-targeting antibiotics examined, including macrolides, lincosamides, streptogramin
B, chloramphenicol, and thiostrepton. It is also sensitive to kirromycin and fusidic acid, which
target protein synthesis factors. It is sensitive to rifampicin (RNA polymerase inhibitor) and to the
fluoroquinolones ofloxacin and ciprofloxacin (DNA gyrase inhibitors), but insensitive to nalidixic acid.
Drug-resistant mutants were identified using rifampicin, thiostrepton, erythromycin, spiramycin,
tylosin, lincomycin, and chloramphenicol. The majority of these were found to have mutations that
are similar or identical to those previously found in other species, while several novel mutations
were identified. This study provides potential selectable markers for genetic manipulations and
demonstrates the feasibility of using R. marinus as a model system for studies of ribosome and RNA
polymerase structure, function, and evolution.
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Extremophilic organisms are important model systems for investigating macromolecular structure, function and evolution. Macromolecular complexes such as the ribosome
are important antibiotic targets and their structural studies have significantly advanced our
understanding of antibiotic modes of action and mechanisms of antibiotic resistance [1–3].
Ribosomes from thermophiles have historically been attractive targets for structural studies due to their greater conformational homogeneity. Such investigations can potentially
reveal the basis for adaptation to extreme environments, especially when coupled to genetic approaches. While the most thoroughly examined thermophilic organism is the
bacterium Thermus thermophilus, studies of other, phylogenetically distant thermophiles
could potentially facilitate a comparative approach. This is especially relevant to the extent
that species-specific idiosyncrasies, such as differences in DNA repair patterns or codon
usage bias, can influence the spectrum of mutants arising. Such idiosyncrasies provide a
compelling motivation to explore novel model systems.
Rhodothermus marinus R-10T is a Gram-negative, non-motile, non-spore-forming, thermophilic and halophilic bacterium isolated from a submarine hot spring off the coast of
Iceland [4]. It grows optimally at a temperature of 65 ◦ C and a salinity of approximately
2%, making it both a model thermophile and a model halophile [5]. Based on 16S rRNA
sequence comparisons, the genus Rhodothermus has been classified as a member of the
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Rhodothermaceae, branching deeply within the phylum Bacteroidetes, with its closest relative
being the mesophilic, extremely halophilic genus Salinibacter [6,7]. Other genera of the
Rhodothermaceae include Salisaeta [8], Rubricoccus [9], Rubrivirga [10], Longimonas [11], and
Longibacter [12]. All members are halophilic and either aerobic or facultatively anaerobic; all but Rhodothermus are mesophilic, suggesting that adaptation of Rhodothermus to
growth at high temperature is a derived rather than a primitive character. Its affinity with
Salinibacter suggests that adaptation to hypersaline environments predates development of
thermostability. This stands in contrast to members of the genus Thermus, which form part
of a phylum that branches deeply in the universal phylogenetic tree, and for whom thermal
adaptation is likely a primitive character. Interestingly, R. marinus was isolated from the
same environmental sample as the halotolerant IB-21 strain of Thermus thermophilus [13],
providing an opportunity to compare independently arising adaptations to the same thermal environment. This species is thus of great intrinsic interest from the standpoint of
microbial evolution.
We have begun to develop R. marinus as a model system for genetic and structural
studies of the ribosome and potentially other macromolecular complexes. Like other
extremophiles, R. marinus has become an important subject of protein structural studies.
Notable examples include a novel respiratory complex III [14] and the ribosomal protein
uL16 arginyl hydroxylase [15]. Although structures of DNA gyrase, RNA polymerase, and
the ribosome from R. marinus have yet to be solved, these would seem promising subjects
for structural studies given their important roles as targets for major antibiotic classes.
Here, we describe antibiotic-resistant mutants of R. marinus with alterations in cellular
components responsible for gene expression.
R. marinus has a number of advantages as a potential model organism for the study
of the protein synthesis. In contrast to most other bacteria, the R. marinus genome has a
single rrn operon [16,17], facilitating the isolation of rRNA mutants with pure populations
of mutant ribosomes. Early attempts to isolate E. coli rRNA mutants were hampered by the
presence of seven rrn operons such that even dominant mutations arising in a single operon
fail to express a selectable phenotype; isolation of such mutants required either expression
of rRNA from multi-copy plasmids [18] or deletion of multiple rrn operons [19]. In general,
ribosome structural studies can be impaired by the complication of mixed populations of
mutant and wild-type ribosomes from species with multiple rrn operons. More recently,
isolation of pure rRNA mutants of Mycobacterium spp. [20] or T. thermophilus [21] has been
facilitated by deletion of one of only two rRNA operons. In the latter organism, isolation
of antibiotic-resistant mutants could also arise by efficient homologous recombination
between rRNA gene copies during antibiotic selection [22]. While R. marinus is not naturally
competent for transformation, a method of DNA transfer by electroporation has been
described [23] and targeted gene disruptions have been constructed [24]. There is thus
significant potential for developing this species as a genetic system [25].
Here, we describe a collection of R. marinus mutants having base substitutions in
rRNA, or amino acid substitutions or deletions in ribosomal proteins or RNA polymerase.
In most instances, these mutations are similar or identical to those found in T. thermophilus
or mesophilic bacteria. Some mutations, specifically those affecting ribosomal protein uL4,
have not been previously observed.
2. Results
2.1. Spectrum of Antibiotic Sensitivity
Before selecting resistant mutants, we established the range of antibiotics inhibitory to
R. marinus. Although the sensitivity of R. marinus to several antibiotic classes was reported
in the initial description of the genus [4], we undertook a more expansive survey. This was
done using a simple zone of inhibition disc assay (see Materials and Methods). Results
from these assays are indicated in Tables 1 and S2. We examined antibiotics targeting
the ribosome and associated factors, as well as drugs targeting RNA polymerase or DNA
gyrase. Assays showing no zone of inhibition were interpreted as indicating resistance.
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Table 1. Antibiotic sensitivity spectrum of R. marinus R-10T . Sensitivity was assessed using a disc assay to measure zones
of inhibition.
Antibiotic Class, (Target)
aminoglycoside (ribosome, 30S)
aminocyclitols (ribosome, 30S)
tuberactinomycin (ribosome, 70S)
14-atom macrolides (ribosome, 50S)
15-atom macrolide (ribosome, 50S)
16-atom macrolides (ribosome, 50S)
lincosamides (ribosome, 50S)
streptogramin B (ribosome, 50S)
pleuromutilin (ribosome, 50S)
amphenicol (ribosome, 50S)
thiopeptide, (ribosome, 50S)
elfamycin (EF-Tu) 1
fusidane (EF-G) 2
rifamycin (RNA polymerase)
quinolone (DNA gyrase)
fluoroquinolones (DNA gyrase)
1

Antibiotic
streptomycin, apramycin, hygromycin B, gentamicin, neomycin,
neamine, ribostamycin, kanamycin, tobramycin, paromomycin
kasugamycin, spectinomycin
capreomycin
erythromycin, oleandomycin, roxithromycin, clarithromycin
azithromycin
spiramycin, chalcomycin, tylosin, carbomycin
lincomycin, clindamycin
pristinamycin
tiamulin
chloramphenicol
thiostrepton
kirromycin
fusidic acid
rifampicin
nalidixic acid
ofloxacin, ciprofloxacin

Response
resistant
resistant
resistant
sensitive
sensitive
sensitive
sensitive
sensitive
sensitive
sensitive
sensitive
sensitive
sensitive
sensitive
resistant
sensitive

EF-Tu, protein synthesis elongation factor Tu. 2 EF-G, protein synthesis elongation factor G.

We found R. marinus to be insensitive to all 30S ribosomal subunit antibiotics we
tested. We confirmed the previous report of intrinsic resistance of R. marinus to the aminoglycosides streptomycin, kanamycin and gentamicin [4] and also found resistance to
a number of other aminoglycosides (apramycin, tobramycin, neomycin, paromomycin,
neamine, ribostamycin, and hygromycin B). R. marinus is also insensitive to the aminocylitols spectinomycin and kasugamycin. We observed resistance to capreomycin, a member
of the tuberactinomycins, which binds at the 30S–50S subunit interface, consistent with
the previously observed cross-resistance of aminoglycoside-resistant mutants to capreomycin [22,26], suggesting a common basis for insensitivity to both classes of drugs. All
other antibiotics showed significant zones of inhibition. We confirmed sensitivity to lincomycin, erythromycin, chloramphenicol, and pristinamycin, all of which bind in or near
the peptidyltransferase active site of the 50S subunit. Additional macrolides producing inhibition included the 14-atom macrolides oleandomycin, roxithromycin, and clarithromycin,
the 15-atom macrolide azithromycin, and the 16-atom macrolides spiramycin, chalcomycin,
tylosin, and carbomycin. The pleuromutilin tiamulin, another inhibitor of peptide bond
formation, also inhibits growth of R. marinus. In summary, R. marinus is resistant to all
30S inhibitors tested and sensitive to all 50S subunit inhibitors tested. Sensitivity was also
found to kirromycin and fusidic acid, which target protein synthesis factors EF-Tu and
EF-G, respectively. Among non-ribosomal drugs, we found R. marinus to be sensitive to
the RNA polymerase inhibitor rifampicin and to the DNA gyrase inhibitors ofloxacin and
ciprofloxacin, but, as previously reported [4], insensitive to nalidixic acid.
2.2. Selection of Spontaneous Mutants
Selection of resistant mutants was attempted with a number of drugs, including the
RNA polymerase inhibitor rifampicin, the protein synthesis inhibitors chloramphenicol,
lincomycin, erythromycin, spiramycin, tylosin, oleandomycin, thiostrepton, and fusidic
acid, and the gyrase inhibitors ofloxacin and ciprofloxacin. Resistant mutants arose on rifampicin, chloramphenicol, lincomyin, erythromycin, spiramycin, tylosin and thiostrepton.
No mutants appeared on oleandomycin, fusidic acid, ofloxacin or ciprofloxacin, although a
more exhaustive search on a wider range of drug concentrations could potentially reveal
mutants resistant to these drugs. Individual isolates were purified and analyzed by sequencing the genes known from previous studies to be the likely sites of mutations. Based
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found independently in selections for erythromycin- (EryR ), spiramycin- (SpiR ), tylosin(TylR ), and lincomycin-resistant (LinR ) mutants.
Table 2. Mutations identified in this study. Abbreviations: Rep Strain, representative strain; Chl,
chloramphenicol; Ery, erythromycin; Spi, spiramycin; Tyl, tylosin; Lnc, lincomycin; Thi, thiostrepton;
Rif, rifampicin.
Allele

Rep Strain

Mutation

Selection

rpoB1
rpoB2
rpoB3
rrlA1
rrlA2
rrlA3
rrlA4
rrlA5
rrlA6
rrlA7
rrlA8
rrlA9
rrlA10
rrlA11
rrlA12
rrlA13
rrlA14
rrlA15
rrlA16
rrlA17
rrlA18
rrlA19
rrlA20
rplD1
rplD2
rplD3

SOP89
SOP90
SOP91
SOP9
SOP23
SOP11
SOP26
SOP56
SOP29
SOP38
SOP74
SOP5
SOP4
SOP1
SOP3
SOP14
SOP7
SOP24
SOP60
SOP72
SOP79
SOP73
SOP77
SOP57
SOP25
SOP16

RNA pol β subunit-V146F
RNA pol β subunit-A522V
RNA pol β subunit-H526Y
23S rRNA-G2057A
23S rRNA-A2058C
23S rRNA-A2058G
23S rRNA-A2059G
23S rRNA-G2061C
23S rRNA-A2062C
23S rRNA-A2062G
23S rRNA-A2453C
23S rRNA-U2500A
23S rRNA-A2503C
23S rRNA-A2503G
23S rRNA-U2504G
23S rRNA-U2611G
23S rRNA-A2453C/U2500A
23S rRNA-G2057A/A2062G
23S rRNA-A2062G/A2503G
23S rRNA-A1067C
23S rRNA-∆A1069
23S rRNA-A1069AA
23S rRNA-G1071GG
uL4-K58N, ∆L59-Y60
uL4-∆A50-R69
uL4-∆T65-G82

Rif50, 100
Rif50, 100
Rif50
Ery50, 100, 200
Ery200
Ery50, 100, 200/Spi100/Tyl100/Lnc100
Ery200/Chl100
Chl100/Lnc100
Chl25/Ery50/Spi100
Chl25/Ery50
Chl25
Chl50
Chl50
Chl25, 50
Chl25, 50
Ery50
Chl50
Ery200
Spi100
Thi200
Thi100
Thi200
Thi100
Ery100, 200
Ery200
Ery100

In addition, several double mutants were identified. These include A2453C/U2500A,
selected on chloramphenicol; G2057A/A2062G, selected on erythromycin; and A2062G/
A2503G, selected on spiramycin. The A2062G/A2503G double substitution is especially
interesting in that A2062 and A2503 form a symmetrical base pair with one another via
their Hoogsteen faces with two N6-N7 hydrogen bonds; either mutation alone could be
isolated on chloramphenicol, while A2062G was isolated on either chloramphenicol or
erythromycin (Figure 3). The appearance of multiple base substitutions is unusual and
not easily explained but could be indicative of a high natural mutation frequency or stressinduced mutagenesis. Our protocols for selection of mutants are designed to minimize
exposure to drug. Further studies will be needed to address this question. All of these
residues are within close proximity to the corresponding drug binding sites as observed in
T. thermophilus ribosome crystal structures (Figure 3B,C) [33].
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conservation of rRNA sequence and structure in ribosome functional centers, and the
catalytic center of RNA polymerase.
A number of high-resolution structures of the T. thermophilus RNA polymerase have
been determined in various complexes [41–43], including with rifampicin [44]. More
recently, the structure of the M. smegmatis RNA polymerase-rifampicin complex has been
solved [28]. Of the R. marinus RNA polymerase residues mutated in RifR mutants, V146
and H526 are both quite conserved, whereas A522 is less so. Substitutions at H526 are
among the more frequently observed RifR mutations in Mycobacterium tuberculosis [27]. As
seen in the M. smegmatis RNA polymerase-rifampicin complex [28], all three residues are
within the rifampicin binding site, although A522 is somewhat removed from rifampicin
such that the mechanism of resistance caused by substitutions at this position is unclear
(Figure 1B). It is perhaps worth noting that this position is a Ser in E. coli, M. tuberculosis,
and T. aquaticus. While none of these residues make direct contact with the drug, their
exchange with bulkier residues is likely to have a strong steric effect on drug binding.
Crystal structures of antibiotics bound to the peptidyltransferase center help to explain
their mechanism of action [3]. As illustrated in Figure 3, base substitutions conferring drug
resistance are components of the drug binding site. In the case of erythromycin-resistance,
sites of mutations are located in close proximity to the drug, and the same is true for
chloramphenicol-resistance. Consistent with this observation, mutations simultaneously
conferring resistance to both drugs are located between the two drug binding sites. Further,
crystal structures of ribosomes containing antibiotic-resistance mutations show small
perturbations in local structure or indicate a loss of ribosome-drug contact [45]. In contrast
to sites of rRNA mutations, ribosomal protein mutations are less similar across species. This
is probably in part due to the lower conservation of ribosomal protein sequences, but more
likely the lack of conservation at the DNA sequence level, which constrains the specific
mutations that can occur. The deletion mutations in rplD observed in R. marinus are the
result of recombination between short, fortuitously repeated DNA sequences. Synonymous
codons at either of these repeats would presumably prevent these particular deletions
from arising.
The finding of deletion mutations in uL4 is consistent with previously identified
mutations in this protein. The original E. coli eryA allele of rplD was found to result in
a single amino acid substitution, K63E [37] (Figure 4B). This mutation was subsequently
found to cause an increase in the frequency of translational errors, including misreading
errors and frameshifting [46]. While an assay for measuring translational accuracy does
not yet exist for R. marinus, it should be possible to assess their effects by reconstructing
the analogous deletions in E. coli rplD. While there is as yet no high-resolution structure
of the R. marinus ribosome, structures of ribosomes from a variety of organisms indicate
that the loop subjected to these deletion mutations is located in close proximity to 23S
rRNA residues involved in erythromycin binding. A wide variety of amino acid substitutions as well as small deletions (1 to several residues) in this loop have been found in
multiple species.
The lack of direct contact between uL4 and erythromycin demands consideration of
an indirect mechanism of resistance, such as a local destabilization of rRNA conformation.
The deletions could be mapped onto the T. thermophilus ribosome crystal structure and
it is clear that they must abolish any direct contact with 23S rRNA in the erythromycin
binding site (Figure 4C–E). This notion is consistent with a previous chemical probing
study [47] and subsequent cryo-electron microscopic reconstruction [48] of the E. coli
uL4 mutant, both of which showed significant structural distortion from a single amino
acid substitution. We would expect the R. marinus deletions to make substantially greater
distortions. A crystal structure of an archaeal 50S subunit bearing a 3 amino acid deletion in
ribosomal protein uL22 shows the repositioning of several bases in the peptidyltransferase
center [45]. Remarkably, the extended loops of both uL4 and uL22 of E. coli are dispensable
for protein synthesis and growth but make important contributions to the kinetics and
fidelity of 50S subunit assembly [40]. We expect that the deletions within uL4 will show
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extensive distortions, and future cryo-EM reconstructions of the R. marinus ribosome could
be effective in testing this hypothesis.
The finding that R. marinus is resistant to aminoglycosides, capreomycin, kasugamycin,
and spectinomycin, was unexpected. One possible explanation is an inability to import
these drugs into the cell, and given the close structural relationship of the aminoglycosides,
a common uptake mechanism seems plausible. Members of the Bacteroides genus are inherently resistant to aminoglycosides due to lack of an oxygen- or nitrate-dependent electron
transport system [49]. This explanation is insufficient to explain resistance of R. marinus,
which is obligately aerobic. Another possibility is natural variation in ribosome structure.
Inspection of the 16S rRNA sequence revealed variation in the aminoglycoside binding
site, a A1409-U1491 base pair, as opposed to the C1409-G1491 more frequently found in
bacterial 16S rRNAs. Data retrieved from the Comparative RNA Web Site and Project
database (http://www.rna.ccbb.utexas.edu; accessed on 9 August 2020) [50] indicate that
among bacterial sequences, a C-G pair is found in 84.5% of bacterial 16S rRNA sequences,
while an A-U base pair is found in 12.6% of sequences. These data also indicate that
the adjacent base pair, 1410–1490, is C-G in R. marinus, a sequence found in only 0.1% of
bacterial 16S rRNA sequences. The mesophilic extreme halophile Salinibacter ruber, whose
closest relative is R. marinus, is also resistant to kanamycin and its 16S rRNA also has
the A1409-U1491 base pair [6,7]. Based on secondary structure models retrieved from the
RNAcentral database (http://rnacentral.org/; accessed on 9 August 2020) [51], this same
A-U base pair is present in all members of the Rhodothermaceae. Whether or how either of
these base pair identities might influence the aminoglycoside binding site is not obvious.
Previous studies have found the aminoglycoside-resistance mutations C1409G of yeast
mitochondrial 17S rRNA [52], or a G1491A of Tetrahymena thermophila 18S rRNA [53]. This
would also explain the resistance to capreomycin, as these mutations confer cross-resistance
to tuberactinomycins. In the absence of an in vitro protein synthesis system for R. marinus,
it is not yet possible to distinguish between these two possible explanations for resistance
to aminoglycosides and capreomycin.
4. Materials and Methods
4.1. Strains and Growth Conditions, Assessment of Antibiotic Sensitivity, and Isolation
of Mutants
All mutants were derived from R. marinus R-10T ATCC 43812/DSM 4252 [4], which
was a kind gift of JHD Cate, University of California, Berkeley. R. marinus was cultivated
in liquid TEM medium (ATCC Medium 1598) containing 2% NaCl (referred to hereafter
as TEMS medium) or on TMG medium containing 2% NaCl (referred to hereafter as
TMGS medium). TMG medium consists of TEM lacking phosphate buffer and solidified
with gelrite at a concentration of 1.1%. All cultures were grown at 65 ◦ C under aerobic
conditions with vigorous aeration at 200 rpm in a New Brunswick Innova 42 Shaker
Incubator. Overnight cultures were typically cultivated in 20 mL of medium in 125 mL
baffled culture flasks (Corning).
To assay antibiotic sensitivity, 100 µL of a saturated overnight culture grown in TMGS
broth was spread-plated onto TMGS plates. A disc infused with 100 µg of antibiotic was
placed onto the surface of the plate, which was then incubated at 65 ◦ C overnight; zones of
inhibition were subsequently measured. Spontaneous mutants were selected by spreading
approximately 109 cells from a saturated overnight culture onto TMGS plates containing
various antibiotic concentrations; chloramphenicol, 25, 50, or 100 µg/mL; erythromycin, 50,
100, or 200 µg/mL; tylosin, 100 µg/mL; spiramycin, 100 µg/mL; lincomycin, 100 µg/mL;
thiostrepton, 25, 50, 100, or 200 µg/mL; rifampicin, 50, 100, or 200 µg/mL. Mutants were
purified by restreaking onto TMGS medium containing antibiotic at the same concentration
used in selection, then a second time on antibiotic-free TMGS. Mutants were never exposed
to antibiotic after the initial single colony isolation. Single colonies were used to inoculate
TEMS medium and shaken at 65 ◦ C to saturation. Mutants were archived as 25% glycerol
stocks at −80 ◦ C.
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4.2. Identification of Mutations
Chromosomal DNA (gDNA) was prepared using Wizard Genomic DNA Kit (Promega,
Madison, WI, USA). Oligonucleotide primers were synthesized by IDT and are described
in Supplementary Table S1. All PCR reactions were performed using OneTaq DNA polymerase (New England Biolabs, Ipswich, MA, USA). Sanger sequencing of PCR products
was performed by the Genomics and Sequencing Center at The University of Rhode
Island. The rrnA operon encoding 16S rRNA (locus tag RMAR_RS00885), tRNAIle (locus tag RMAR_RS00890), tRNAAla (locus tag RMAR_RS00895), 23S rRNA (locus tag
RMAR_RS00900), and 5S rRNA (locus tag RMAR_ RS00905), was amplified using primers
Rma_rrnA_f3 and Rma_rrnA_r3, with a 58 ◦ C annealing temperature and a 6 min extension
time. The rplD gene encoding ribosomal protein uL4 (locus tag RMAR_RS04205) was amplified using primers Rma_rplD_f1 and Rma_rplD_r1, with a 52.5 ◦ C annealing temperature
and a 1 min extension time. The rplV gene encoding ribosomal protein uL22 (locus tag
RMAR_RS04225) was amplified using primers Rma_rplV_f1 and Rma_rplV_r1, with a
49 ◦ C annealing temperature and a 1 min extension time. The rplK gene encoding ribosomal protein uL11 (locus tag RMAR_RS05505) was amplified using primers Rma_rplK_f1
and Rma_rplK_r1, with a 60 ◦ C annealing temperature and a 1 min extension time. The
rpoB gene encoding the β-subunit of RNA polymerase (locus tag RMAR_RS05525) was
amplified using primers Rma_rpoB_f1 and Rma_rpoB_r1, with a 49 ◦ C annealing temperature and a 4 min extension time. Sequencing of the rrlA gene encoding 23S rRNA
was performed using primers Rma_rrnA_f4, Rma_rrnA_f7, Rma_rrnA_f8, Rma_rrnA_r5,
Rma_rrnA_r6, Rma_rrnA_r7.
5. Conclusions
Antibiotic sensitivity spectra and patterns of cross resistance can potentially be informative from both phylogenetic and ribosome structure-function perspectives. Extensive
surveys of antibiotic-resistance mutations have been conducted for only a handful of
species, making broad generalizations difficult. In this study, we have isolated and characterized a number of antibiotic-resistant mutants of a single species, potentially allowing
direct comparisons of mutant phenotypes. Importantly, we find that mutations arising
in a thermophilic-halophilic species closely resemble those found in mesophilic species,
consistent with the extreme sequence conservation (and by implication, structural conservation) of antibiotic-binding sites in RNA polymerase and the ribosome. Surprising
was the inherent resistance of this species to a range of structurally-unrelated 30S subunit
inhibitors. The basis for this resistance remains to be determined. The ability to readily
isolate rRNA mutations in this species makes it a candidate for future structural studies to
address this question.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/antibiotics10111384/s1, Figure S1: Generation of rplD erythromycin-resistance mutations [54];
Table S1: Oligonucleotides used in this study [17]; Table S2: Antibiotic zones of inhibition.
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